ATRANTIL
Live / Registered — Registered and renewed (as of 04 Nov 2025)
What this means for you
Registered since 22 Sept 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2025).
Record
- Serial number
- 86977039
- Registration number
- 4819934
- Mark type
- Stylized text
- Filed
- 07 Nov 2014
- Published for opposition
- 07 Apr 2015
- Registered
- 22 Sept 2015
- Next maintenance due
- 22 Sept 2025
- Attorney of record
- Rebecca A. Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for the treatment of bloating, abdominal discomfort, constipation
Owner
- KBS Research, LLC, Dallas, TX, US
- KBS Research, LLC, Dallas, TX, US
- KBS Research, LLC, Plano, TX, US
Prosecution history
- 04 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Nov 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Nov 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 22 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Nov 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Aug 2021 — TEAS SECTION 8 & 15 RECEIVED
- 22 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 19 Aug 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Aug 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Aug 2015 — STATEMENT OF USE PROCESSING COMPLETE